The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project

Table 4

The distribution of antiparkinsonian therapy used in the patients studied.

Therapies	Patients (𝑛)	Percent (%)
Drug naïve	12	8.89
Levodopa monotherapy	50	37.04
DA monotherapy	11	8.15
Levodopa + DA	61	45.19
Others	1	0.74

DA: dopamine agonists.